MedKoo Cat#: 575625 | Name: Foropafant fumarate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SR 27417A is a PAF-receptor antagonist.

Chemical Structure

Foropafant fumarate
Foropafant fumarate
CAS#136470-45-6 (fumarate)

Theoretical Analysis

MedKoo Cat#: 575625

Name: Foropafant fumarate

CAS#: 136470-45-6 (fumarate)

Chemical Formula: C32H44N4O4S

Exact Mass: 580.3083

Molecular Weight: 580.79

Elemental Analysis: C, 66.18; H, 7.64; N, 9.65; O, 11.02; S, 5.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Foropafant fumarate; SR 27417A; SR27417A; SR-27417A
IUPAC/Chemical Name
1,2-Ethanediamine, N,N-dimethyl-N'-(3-pyridinylmethyl)-N'-(4-(2,4,6-tris(1-methylethyl)phenyl)-2-thiazolyl)-, (2E)-2-butenedioate (1:1)
InChi Key
VVMIAYBAROQMMT-WLHGVMLRSA-N
InChi Code
InChI=1S/C28H40N4S.C4H4O4/c1-19(2)23-14-24(20(3)4)27(25(15-23)21(5)6)26-18-33-28(30-26)32(13-12-31(7)8)17-22-10-9-11-29-16-22;5-3(6)1-2-4(7)8/h9-11,14-16,18-21H,12-13,17H2,1-8H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
SMILES Code
CC(C)c1cc(C(C)C)c(c(c1)C(C)C)c2csc(n2)N(CCN(C)C)Cc3cccnc3.OC(=O)\C=C\C(=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 580.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Gómez FP, Roca J, Barberà JA, Chung KF, Peinado VI, Rodriguez-Roisin R. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. Eur Respir J. 1998 Apr;11(4):835-9. doi: 10.1183/09031936.98.11040835. PMID: 9623685.